American Well Corporation (AMWL)
| Market Cap | 102.37M |
| Revenue (ttm) | 249.33M |
| Net Income (ttm) | -95.70M |
| Shares Out | 16.55M |
| EPS (ttm) | -5.96 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,357 |
| Open | 6.09 |
| Previous Close | 6.14 |
| Day's Range | 6.05 - 6.19 |
| 52-Week Range | 3.71 - 9.15 |
| Beta | 1.39 |
| Analysts | Hold |
| Price Target | 7.40 (+19.64%) |
| Earnings Date | May 5, 2026 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into th... [Read more]
Financial Performance
In 2025, American Well's revenue was $249.33 million, a decrease of -1.98% compared to the previous year's $254.36 million. Losses were -$95.70 million, -54.02% less than in 2024.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $7.4, which is an increase of 19.64% from the latest price.
News
Amwell® to report first quarter 2026 operating results
BOSTON, April 20, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report first quarter 2026 o...
American Well Transcript: TD Cowen 46th Annual Health Care Conference
Virtual healthcare is challenged by market fragmentation, but growth is driven by payer and government segments. Major contracts like Elevance and DHA support revenue stability, with AI integration enhancing efficiency. 2026 guidance targets $195–$205M revenue and EBITDA breakeven, with strong cash reserves and new government opportunities expected.
Amwell® to Participate in Upcoming Investor Conference
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschh...
Amwell makes grant to new employee under inducement plan
BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announced that on February 18, A...
American Well Earnings Call Transcript: Q4 2025
2025 saw a strategic transformation to a unified tech platform, with divestitures and cost reductions leading to improved margins and a higher-quality revenue base. 2026 guidance projects lower revenue but improved profitability, with positive cash flow expected in Q4.
Amwell® Announces Results for Fourth Quarter and Full Year 2025
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results...
Amwell® to report fourth quarter and full year 2025 operating results
BOSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report fourth quarter and fu...
American Well Earnings Call Transcript: Q3 2025
Q3 revenue and adjusted EBITDA exceeded expectations, driven by higher subscription revenue, cost efficiencies, and a shift to a more software-focused model. The company is divesting non-core assets, investing in AI, and expects positive cash flow from operations by end of 2026.
Amwell® Announces Results for Third Quarter 2025
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial result...
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report third quarter 2025 op...
American Well Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference
The company is accelerating its shift to a technology-enabled care model, focusing on unified, AI-driven platforms and high-margin software solutions. Recent government wins, cost reductions, and a clear mission position it for growth and profitability by 2026.
Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 7...
American Well Earnings Call Transcript: Q2 2025
Q2 2025 featured strong revenue growth, margin expansion, and a key MHS contract extension, though guidance was revised lower due to government budget constraints. Cost initiatives and a focus on subscription software are driving improved EBITDA and a path to positive cash flow in 2026.
Amwell® Announces Results for Second Quarter 2025
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extensi...
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 o...
American Well Transcript: AGM 2025
The meeting covered director elections, auditor ratification, and executive compensation approval, with all proposals recommended by the board. Quorum was established, voting was conducted online, and final results will be filed with the SEC.
American Well Earnings Call Transcript: Q1 2025
Q1 2025 saw strong software revenue growth, margin expansion, and improved adjusted EBITDA, driven by large-scale deployments and cost reductions. Guidance for 2025 is reiterated, with positive cash flow from operations targeted for 2026, contingent on DHA contract renewal.
Amwell® Announces Results for First Quarter 2025
BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first ...
Amwell® to participate in upcoming investor conferences
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the followi...
Amwell® to report first quarter 2025 operating results
BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. F...
American Well Transcript: TD Cowen 45th Annual Healthcare Conference
Digital health adoption is accelerating, with a major SaaS deployment for the Defense Health Agency nearly complete and expected to drive significant revenue growth. The platform’s unified approach is resonating with payers and providers, while cost reductions and a strong cash position support a path to profitability by 2026.
Amwell makes inducement grant
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, today announced that, on March 3, 2025, it made a grant of restricted stock units (“RSUs”) coveri...
Amwell announces innovation leader as chief product and technology officer
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in technology-enabled care, announced Dan Zamansky, an industry leader in innovation and technology, as the company's new chi...
Amwell® makes grants to new employees under inducement plan
BOSTON, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on Feb. 18, Amwell made grants of RSUs covering an aggregate of 16...